Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thrombosis 3Neoplasms 3Venous Thromboembolism 2Pulmonary Embolism 2Thrombosis 1Prostatic Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hot Flashes 1Cushing Syndrome 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

apixaban 18Dalteparin 15Rivaroxaban 11Enoxaparin 10Heparin, Low-Molecular-Weight 8Aspirin 8Tinzaparin 7Warfarin 3Fondaparinux 3edoxaban 2bemiparin 2abelacimab 2Rosuvastatin Calcium 2Nadroparin 2MAA868 2Dabigatran 2sotorasib 1reviparin 1isoquercitrin 1enoxaparin sodium 1certoparin 1betrixaban 1argatroban 1acarboxyprothrombin 1Tacrolimus 1Tablets 1Simvastatin 1Platelet Transfusion 1Phenprocoumon 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Venous Thromboembolism × Dabigatran × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡